Lung transplantation remains the only therapeutic option shown to improve survival for many end-stage interstitial lung diseases. Although idiopathic pulmonary fibrosis is the most common indication, transplantation has been performed for many other diseases. This article reviews the current indications and outcomes for the procedure and problems encountered in lung transplantation for interstitial lung diseases. The role of transplant for specific diseases also is discussed.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.ccm.2004.04.008 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!